Yong Jun Jin

Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy

Chemically Modified Platforms for Better RNA Therapeutics

Preparation and Preliminary Evaluation of Dual-functional Nanoparticles for MRI and siRNA Delivery.

Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer